3rd Quarter - Report — SOCIETY OF NUCLEAR MEDICINE AND MOLECUL… for SOCIETY OF NUCLEAR MEDICINE AND MOLECUL… (2014)

Firm

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Client

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Income

—

Expenses

$80,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
CAITLIN BLAKE KUBLER	—

Contacted: HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3204 (113th)

Medicare/Medicaid MMM

Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014).

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 4302 (113th)

Budget/Appropriations BUD

FY'15 Energy/Water Appropriations (HR 3547, the Consolidated Appropriations Act) regarding DOE funding opportunities for nuclear medicine research. Funding for the National Nuclear Chemistry Summer School. FY'15 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
CAITLIN BLAKE KUBLER	—
JESSE SCHOOLNIK	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Nuclear Regulatory Commission (NRC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3547 (113th)

Energy/Nuclear ENG

Domestic isotope supply issues, including oversight of the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

The 21st Century Cures Initiative generally; and the creation of a new drug approval pathway at the FDA specifically.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
CAITLIN BLAKE KUBLER	—

Contacted: Nuclear Regulatory Commission (NRC); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.